My watch list
my.bionity.com  
Login  

15 Current news from poland

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
This computer program makes pharma patents airtight

21-Jan-2019

Routes to making life-saving medications and other pharmaceutical compounds are among the most carefully protected trade secrets in global industry. Building on recent work programming computers to identify synthetic pathways leading to pharmaceutically complex molecules, researchers in Poland ...

more

Felicitex Therapeutics and Selvita Initiate Strategic Collaboration to Target Cancer Quiescence

11-Nov-2014

Felicitex Therapeutics and Selvita announced that they have entered into a strategic collaboration to develop breakthrough personalized cancer therapeutics for some of the deadliest and most resistant cancers, such as pancreatic, colon, ovarian, lung and hematopoietic tumors.During the first ...

more

H3 Biomedicine and Selvita Reach First Research Milestone in Precision Cancer Medicines Collaboration

Companies Advance Multiple Co-discovery Programs for First-in-class Targets in Oncology

27-May-2014

H3 Biomedicine Inc. and Selvita announced that they have achieved the first research milestone in their strategic collaboration to develop breakthrough precision medicines for cancers. The companies have validated the importance and druggability of a kinase target in a specific genetic context ...

more

image description
Microfluidic breakthrough in biotechnology

02-Aug-2013

Chemical flasks and inconvenient chemostats for cultivation of bacteria are likely soon to be discarded. Researchers from the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw were first to construct a microfluidic system allowing for merging, transporting and splitting ...

more

Biobatteries catch breath

11-Mar-2013

An air-breathing bio-battery has been constructed by researchers from the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw. The core element providing the new power source with relatively high voltage and long lifetime is a carefully designed cathode taking up oxygen ...

more

CROMSOURCE further expands polish operations

15-Feb-2013

CROMSOURCE announced the completion and opening of a new office building in Warsaw, Poland and the movement of key company services to this location. ‘Poland has been a key location for CROMSOURCE since our inception in 1994 ', noted Oriana Zerbini MD, Chief Executive Officer of CROMSOURCE. ‘We ...

more

Selvita and Orion Pharma Achieve a Research Milestone in Alzheimer’s Disease Program

03-Jul-2012

Selvita S.A. announced that its collaboration with Orion Corporationon SEL103 program, for the symptomatic treatment of Alzheimer’s disease has reached the main research milestone and that the jointly discovered molecules from two different chemical families will progress into further ...

more

Selvita Ranked the No. 1 Rising Star in Deloitte Technology Fast 50 Central Europe

20-Oct-2011

Selvita S.A. has been ranked as the no.1 Rising Star within this year’s contest of Deloitte Technology Fast 50 in Central Europe.The Central Europe Technology Fast 50 program, is part of a global effort by Deloitte to identify the fastest growing technology companies all over the world, which ...

more

BioCentrum Obtains a Certificate of Good Laboratory Practice (GLP)

23-May-2011

BioCentrum, part of the Selvita Group, received a certificate of compliance with the principles of Good Laboratory Practice (GLP). The certificate was awarded after a successfully completed verification by the Bureau for Chemical Substances (institution of governmental administration granting GLP ...

more

Eckert & Ziegler: new production location in Warsaw being planned

Eckert & Ziegler to become the long-term contrast agent supplier to leading Polish clinic chain

04-Mar-2011

Eckert & Ziegler Strahlen- und Medizintechnik AG has concluded a long-term contract with Euromedic International B.V., based in Budapest, to supply Polish diagnostics centres. The framework agreement for so-called FDG (Fluorodeoxyglucose (18 F)) also envisages the creation of a pharmaceutical ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE